. . . . . . . . . "latanoprost ophthalmic solution is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension latanoprost ophthalmic solution is a prostaglandin f2a analogue indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension 1" . . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "AqrlvN/jp/czDDj3Tfu83DrtZpXZMwWgUwY3Y7wPSjhZ6gNskLp656Gnyr7mraBCUTcajv36Iv6Qg327puOCtG2xjCB1VDAj1umRNGp0GkcF2xDZk5U4DHGx9JiiGLEYkhO0WWlHEQ3E57T0V5WRhLEKCE1FbWdWwQDffzdw9/8=" . . "2021-07-03T14:26:10.870+02:00"^^ . . . . .